Cascadian Therapeutics, Inc.
Profile
Mailing Address: 2601-4th Avenue
Suite 500
Seattle, Washington
98121
Head Office Address: 2601 - 4th Avenue
Suite 500
Seattle, Washington
98121
Contact Name: Julie Rathbun Principal Regulator: Alberta
Business e-mail address: IR@cascadianrx.com Short Form Prospectus Issuer: No
Telephone Number: 206 801-2100 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland, Other than Canada
Fax Number: 206 801-2101 Stock Exchange: NASDAQ
Date of Formation: Sep 7 2007 Stock Symbol: CASC
Jurisdiction Where Formed: Delaware Auditor: Ernst & Young LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 14740B Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents